An autopsy case of Sjögren's syndrome with acute encephalomyelopathy

Internal Medicine

Volumn 47, Issue 19, 2008, Pages 1675-1680

  Yaguchi, Hiroaki ^a   Houzen, Hideki ^a   Kikuchi, Keisuke ^a   Hata, Dai ^a   Ura, Shigehisa ^a   Takeda, Tsuyoshi ^a   Yabe, Ichiro ^b   Sasaki, Hidenao ^b  

^a Obihiro Kosei General Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Enchephalomyelopathy; Myelopathy; NAIM; Nonvasculitic autoimmune inflammatory meningoencephalitis; Pathology; Sj gren's syndrome

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE DISEASE; ADULT; ARTICLE; AUTOPSY; BRAIN DISEASE; BRAIN STEM; CASE REPORT; CAUSE OF DEATH; DEMYELINATION; ERYTHROPHAGOCYTOSIS; FEMALE; GENERAL CONDITION DETERIORATION; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MULTIPLE ORGAN FAILURE; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OGILVIE SYNDROME; SJOEGREN SYNDROME; SPINAL CORD DISEASE; STEROID THERAPY; VASCULITIS;

ADULT; AUTOPSY; BRAIN STEM; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MAGNETIC RESONANCE IMAGING; MULTIPLE ORGAN FAILURE; PREDNISOLONE; SJOGREN'S SYNDROME; SPINAL CORD;

EID: 56349111387     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0207     Document Type: Article

References (28)

1. Fox RI. Sjögren's syndrome. Lancet 366: 321-331, 2005.
2. Delalande S, Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83: 280-291, 2004.
3. Rogers SJ, Williams CS, Roman GC. Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants. Drugs 64: 123-132, 2004.
4. Atherine L. Neurological manifestations in Sjögren's syndrome. Arch Neurol 57: 411-413, 2000.
5. Alexander EL. Neurologic disease in Sjögren's syndrome. In: Handbook of Clinical Neurology. Aminoff MJ, Goetz CG, Eds. Elsevier, Amsterdam, 1998: 59-98.
6. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum 55: 116-121, 1996.
7. Harzheim M, Schlegel U, Urbach H, Klockgether T, Schmidt S. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217: 217-223, 2004.
8. Prineas JW, Mcdonald WI, Franklin RJM. Demyelinating disease. In: Greenfield's Neuropathology. 7th ed. Graham DI, Lantos PL, Eds. Arnold, London, 2002: 471-550.
9. Grossman JM, Kalunian KC. Definition, classification, activity, and damage indices. In: Duboi's Lupus Erythematosus. 6th ed. Wallace DJ, Hahn BH, Eds. Lippincott Williams & Wilkins, Philadelphia, 2001: 19-31.
10. Misu T, Fujihara K, Nakashima I, et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 125: 2460-2468, 2002.
11. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2: 117-127, 2003.
12. Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77: 290-295, 2006.
13. Wang YJ, Tsai KY, Fuh JL, Tsai CP, Wang SJ. High frequency of primary Sjögren's syndrome in Taiwanese patients presenting as relapsing-remitting multiple sclerosis. Eur Neurol 51: 21-25, 2004.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231, 1983.
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127, 2001.
16. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114, 1999.
17. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489, 2006.
18. Wingerchuk DM. Neuromyelitis optica: current concepts. Front Biosci 9: 834-840, 2004.
19. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004.
20. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 128: 2518-2534, 2005.
21. Dyck PJ, Dyck PJB, Engelstand J. Pathologic alterations of nerves. In: Peripheral Neuropathy. Volume 1. 4th ed. Dyck PJ, Thomas PK, Eds. Elsevier Saunders, Philadelphia, 1993: 733-831.
22. Kaltreider HB, Talal N. The neuropathy of Sjögren's syndrome: trigeminal nerve involvement. Ann Intern Med 70: 751-762, 1969.
23. Alexander GE, Provost TT, Stevens MB, Alexander EL. Sjögren's syndrome: central nervous system manifestations. Neurology 31: 1391-1396, 1981.
24. Rutan G, Martinez AJ, Fieshko JT, Van Thiel DH. Primary biliary cirrhosis, Sjögren's syndrome, and transverse myelitis. Gastroenterology 90: 206-210, 1986.
25. Ichikawa H, Ishihara K, Fujimoto R, et al. An autopsied case of Sjögren's syndrome with massive necrotic and demyelinating lesions of the cerebellar white matter. J Neurol Sci 225: 143-148, 2004.
26. Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology 53: 1579-1581, 1999.
27. Caselli RJ, Scheithauer BW, Bowles CA, Trenerry MR, Meyer FB, Smigielski JS, et al. The treatable dementia of Sjögren's syndrome. Ann Neurol 30: 98-101, 1991.
28. Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology 24: 149-152, 2004.